Z-1954-2021 Class I Terminated

Recalled by Magellan Diagnostics, Inc. — North Billerica, MA

FDA device recall Z-1954-2021 was initiated by Magellan Diagnostics, Inc. on May 7, 2021 and is designated Class I. Reason for recall: Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient… The recall status is terminated (terminated Oct 24, 2023). Affected quantity: 441 kits (192 tests/kit = 84,672 tests).

Recall details

Product Type
Devices
Report Date
Jul 7, 2021
Initiation Date
May 7, 2021
Termination Date
Oct 24, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
441 kits (192 tests/kit = 84,672 tests)

Product description

LeadCare Ultra Blood Lead Test Kit Catalog Number 70-8098

Reason for recall

Magellan has received reports that control tests of either the Low-Control and/or the High-Control generated a low result. The issue may cause the underestimation of blood lead levels in patient samples.

Distribution pattern

Worldwide distribution. US nationwide including Puerto Rico; Canada, Vietnam, India, Italy, Peru, New Zealand, Australia, Hong Kong, and Philippines.

Code information

Lot Numbers/Expiration Date: 2011MU - 25MAR22. 1st expansion 6/21/2021: 2104MU - 25AUG22; 2108MU - 31MAR22.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1954-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1954-2021. Report a data issue: hello@regdatalab.com.